Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johnson & Johnson (Innovative Medicine/Janssen) currently markets dozens of major medicines with numerous late-stage candidates across oncology, immunology, neuroscience, infectious diseases, and metabolic/cardiovascular categories. Clinical results include FDA approvals for novel cancer therapies (e.g. INLEXZO™ for bladder cancer), leadership in HIV, autoimmune diseases, and key vaccine innovations (including COVID-19)[7][5][1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Johnson & Johnson (Janssen for some regions).